News-Papers
Testimonial
Video Gallery
Search
Follow us...
Latest
- Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation
- Colorectal cancer, Vitamin D and microbiota: A double-blind Phase II randomized trial (ColoViD) in colorectal cancer patients
- Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors
- An Exclusive Review of Melatonin Effects on Mammalian Melanocytes and Melanoma
- Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation
- A comprehensive analysis-based study of triphenyl phosphate-environmental explanation of glioma progression
- Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation
- The Vitamin D Receptor-BIM Axis Overcomes Cisplatin Resistance in Head and Neck Cancer
- Melatonin Protects Against Cyclophosphamide-induced Premature Ovarian Failure in Rats
- Melatonin inhibits glycolysis in hepatocellular carcinoma cells by downregulating mitochondrial respiration and mTORC1 activity
- Comprehensive analysis of triphenyl phosphate: An environmental explanation of colorectal cancer progression
- Melatonin inhibits ESCC tumor growth by mitigating the HDAC7/β-catenin/c-Myc positive feedback loop and suppressing the USP10-maintained HDAC7 protein stability
- Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival
- Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis
- Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma
- Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells
- The prolactin/growth hormone receptor family
- Somatostatin inhibits hepatic growth hormone receptor and insulin-like growth factor I mRNA expression by activating the ERK and PI3K signaling pathways
Most Read
- The Di Bella Method (DBM)
- All-trans-retinoic acid and cancer
- About melatonin - 1996
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Bibliography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- How effective is chemo therapy?
- Vademecum
- Frequently Asked Questions
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Malignant pleural mesothelioma, stage T3-T4 - Consideration of a case study
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients